Immunic Inc. Reports Third Quarter 2025 Financial Results ...
BioVersys BV100 Phase 2B to be conducted via Wellcome Funded ...
Bioversys ANNOUNCES FIRST SUBJECTS DOSED IN PHASE 1 CLINICAL ...
Aktuelle Forschungsergebnisse belegen dass hoher Zuckerkonsum ...
Energiehunger: Warum das Gehirn Mitochondrien braucht
Immunic to Participate in Industry and Investor Conferences ...
Relief Therapeutics Announces Positive Results from Pivotal ...
Biotechnology Collaboration Aims to Reshape Industrial Solutions ...
Aktuelle Forschungsergebnisse zeigen dass zahlreiche Medikamente ...
GNW-News: Santhera schließt Vereinbarung mit Biomedica ...
c-LEcta bringt neues GMP-Enzym zur Zelldissoziation für ...
ReproNovo Announces Clinical Trial Approval Notice for RPN-001 ...
Immunic Presented Key Vidofludimus Calcium Data at the 41st ...
GNW-News: Basilea schliesst eine Fördervereinbarung mit ...
GNW-News: Santhera gibt die Finanzergebnisse für das erste ...
GNW-News: Santhera gibt die Finanzergebnisse für das erste ...
GNW-News: Santhera sichert sich CHF 20 Millionen Wachstumsfinanzierung ...
Promega and Watchmaker Genomics Announce Strategic Partnership ...
Lateral Flow Assays Market Size will Hit US$ 15.68 Billion ...
Immunic Receives Notice of Allowance for United States Patent ...
AMO Pharma Enters into License Agreement with Population ...
Technical Integration Creates Research Advantage
Immunic to Participate in Investor and Scientific Conferences ...
Rapid Food Safety Testing Market worth $31.22 billion by ...
IFF Tackles Top Challenges in Baking at IBIE 2025
Clostridioides difficile Infection Market Forecasts by DelveInsight ...
Vaccine Refrigerators Market Size to Reach US$ 2.50 Billion ...
Ministry Of Health Labour and Welfare Grants Orphan Drug ...
BRAIN Biotech mit dynamischem Q3-Umsatzwachstum im Kernsegment ...
Corbion and BRAIN Biotech team to shape the future of innovation ...
Pediatric Relapsed/Refractory Neuroblastoma Market is on ...
GNW-News: Basilea gibt Einlizenzierung eines neuartigen ...
GNW-News: Santhera schließt Vereinbarung mit GEN über ...
Mission Therapeutics announces publication in Nature Communications ...
Enzymes Market worth $20.4 billion by 2029 - Exclusive Report ...
Hansa Biopharma Reports Third Quarter and Interim January ...
Basecamp Research launches ZymCTRL a world-first open source ...
Epigenetics Market to be Worth $6.33 Billion by 2031 - Exclusive ...
Global Industrial Enzyme Markets: Innovation Impact and ...
Sentynl Therapeutics Receives MHRA Authorization of NULIBRY® ...
Setting a New Standard for Intelligent Factories: Angel ...
Microplates Market to Reach USD 1 301.08 million by 2032 ...
STORM Therapeutics to Present Data on its First-in-Class ...
TXN Systems Raises SEK 25 Million Series A to Advance First-in-Class ...
BioArctic's global license agreement with Bristol Myers ...
Genethon and Hansa Biopharma announce initiation of a Phase ...
Fertilizers Market worth $281.56 billion by 2030- Exclusive ...
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma ...
Hansa Biopharma Completes Randomization in Pivotal Phase ...
Xanthan Gum Market size worth $ 492.3 Million Globally by ...
Medical Device Packaging Market Poised for Significant Expansion ...
Bakery Enzyme Market to Attain $1.73 Billion at 5.1% CAGR ...
STORM Therapeutics' First-in-Class tRNA methyltransferase ...
PEGylated Proteins Market Set to Reach USD 19.1 Billion ...
Hansa Biopharma Reports Fourth Quarter and Full Year 2024 ...
Waters New Bioseparations Tools Accelerate and Improve Development ...
Avenzo Therapeutics and DualityBio Announce Exclusive Global ...
Estableciendo un nuevo estándar para las fábricas inteligentes ...
Industrial Enzymes Market worth $12.01 billion by 2030- ...
Plastic Additives Market Size to Grow USD 83.8 Billion by ...
Tsingke Successfully Showcases Innovations at BIO-Europe ...
Établir une nouvelle norme pour les usines intelligentes ...
STORM Therapeutics Presented Interim Phase 1 Clinical Data ...
Angel Yeast expandiert in Forschung Entwicklung und Produktion ...
Peptide Synthesis Market to Reach USD 1.12 Billion by 2031 ...
Allozymes and Bonumose Collaborate to Accelerate Enzyme ...
Mission Therapeutics announces publication in Nature Reviews ...
Mission Therapeutics raises £25.2 million to progress clinical ...
STORM Therapeutics to Present Findings on its First-in-Class ...
Specialty Enzymes Market to Surpass USD 10.4 Billion by ...
Mission Therapeutics to Present Abstract at American Society ...
DNA Synthesizer Market worth $754.55 Mn by 2031 - Explained ...
Landmark New Publication: the Forgotten Biochemistry 101 ...
IVD Reagents Market to be Worth $79.76 Billion by 2031 - ...
Hansa Biopharma Reports Second Quarter and Interim January-June ...
Clean Label Starch Market to Reach USD 2.6 Billion by 2032 ...
Myocarditis Treatment Market Size is Projected to Reach ...
Tony Kouzarides Founder of STORM Therapeutics Awarded British ...
Hansa Biopharma presents positive outcomes of five-year ...
Global Glucose Biosensor Market Size to hit $21.3 billion ...
Clinical Biomarkers Market worth $47.25 Bn by 2031 - Exclusive ...
Acurx Announces Publication of Positive Results from an ...
Enzymatica AB's Interim report Q3/2024: Focus on developing ...
Avenzo Therapeutics Announces Global License of AVZO-021 ...
Hansa Biopharma Reports Second Quarter 2024 Financial Results ...
Angel Yeast Brings Together Innovative Consortium to Build ...
Mission Therapeutics granted MHRA Clinical Trial Authorisation ...
Angel Yeast bringt innovatives Konsortium zum Aufbau eines ...
Zymo Research Pioneers a Breakthrough in Large-scale Animal-free ...
Zymo Research Unveils PureRec DSN: The Most Selective Duplex-Specific ...
Norgine welcomes PBS listing in Australia of IFINWIL® for ...
Dairy Cultures Market to Reach $1 473.2 Million Globally ...
Nebulizer Market to Reach $2.3 Billion by 2032 exhibiting ...